MRI Diagnosis of Uterine Leiomyoma: Radiologic Interpretation, Differential Diagnosis, and AI Applications in Precision Gynecologic Imaging
MRI Diagnosis of Uterine Leiomyoma in a 29-Year-Old Woman: Radiologic Interpretation, Pathophysiology, and the Emerging Role of Artificial Intelligence
Clinical Hook
"Doctor, my periods have become heavier every month... and I constantly feel pressure in my lower abdomen."
A 29-year-old woman presented with several months of progressive pelvic pressure, pelvic pain, and prolonged heavy menstrual bleeding. These symptoms had gradually affected her daily activities and quality of life. Magnetic resonance imaging (MRI) was performed to investigate the underlying cause. The examination revealed a large, well-circumscribed mass arising from the anterior wall of the uterus, displacing the urinary bladder anteriorly. The lesion demonstrated low signal intensity on T2-weighted imaging, isointense signal on T1-weighted imaging, and heterogeneous enhancement after contrast administration—features consistent with a uterine leiomyoma.
Although uterine leiomyomas are among the most common benign tumors in women of reproductive age, accurate diagnosis extends far beyond simply identifying a pelvic mass. Modern radiology requires comprehensive interpretation of imaging features, correlation with underlying pathology, assessment of disease burden, and differentiation from other uterine neoplasms. Increasingly, artificial intelligence (AI) and radiomics are also being explored as tools to support lesion characterization and clinical decision-making.
This article analyzes the case from the perspective of a radiologist, integrating MRI findings, pathophysiologic mechanisms, clinical implications, and the evolving role of AI in precision gynecologic imaging.
3. Learning Objectives
After reading this article, readers should be able to:
- Recognize the characteristic MRI features of uterine leiomyoma.
- Correlate MRI findings with the underlying pathophysiology of leiomyoma.
- Differentiate uterine leiomyoma from other uterine masses using imaging.
- Understand the clinical significance of MRI in treatment planning.
- Evaluate the current and future roles of artificial intelligence in gynecologic imaging.
- Appreciate how radiologic interpretation contributes to precision medicine in women's health.
4. Anatomy Review
Normal Anatomy of the Uterus
The uterus is a hollow muscular organ located in the central pelvis between the urinary bladder anteriorly and the rectum posteriorly. It is composed of three major anatomical layers:
- Endometrium – the inner mucosal lining responsible for cyclic menstrual changes and embryo implantation.
- Myometrium – the thick smooth muscle layer from which uterine leiomyomas originate.
- Serosa (Perimetrium) – the outer peritoneal covering of the uterus.
Because leiomyomas arise from the myometrium, their location relative to the uterine wall determines both imaging appearance and clinical presentation. Lesions may be classified as:
- Intramural
- Submucosal
- Subserosal
The attached case demonstrates a large, well-defined mass arising from the anterior uterine wall and exerting mass effect on the urinary bladder.
Clinical Importance of Uterine Anatomy
Understanding normal pelvic anatomy is essential for interpreting MRI because the relationship between the lesion and adjacent organs often explains the patient's symptoms.
In this case, anterior displacement of the bladder by the uterine mass provides a direct anatomical explanation for the patient's pelvic pressure.
Figure 1. Normal Anatomy of the Female Uterus
Illustration of the normal uterus demonstrating the endometrium, myometrium, serosa, cervix, urinary bladder, and adjacent pelvic structures. The diagram highlights the origin of uterine leiomyomas within the myometrium.
5. Case Presentation
Patient History
A 29-year-old woman presented with several months of pelvic pressure, pelvic pain, and prolonged heavy menstrual bleeding. Because of these persistent symptoms, pelvic MRI was performed for further evaluation.
Presenting Symptoms
The source case describes the following symptoms:
- Pelvic pain
- Pelvic pressure
- Heavy menstrual bleeding lasting several days
These symptoms prompted advanced imaging with MRI.
Physical Examination
The attached case document does not provide physical examination findings.
No uterine size, abdominal examination, or pelvic examination findings are reported in the source material.
Clinical Question
What is the nature of the anterior uterine mass identified on MRI, and can imaging confidently distinguish a benign uterine leiomyoma from other uterine neoplasms?
Laboratory Findings
The attached case document does not include laboratory results.
MRI Findings
MRI demonstrated a large, round, well-defined mass arising from the anterior wall of the uterus. The lesion displaced the urinary bladder anteriorly.
Signal characteristics included:
- Low signal intensity on T2-weighted imaging
- Isointense signal on T1-weighted imaging
- Heterogeneous contrast enhancement after gadolinium administration
These imaging characteristics are described in the source case and are consistent with a typical uterine leiomyoma.
Pathology
The discussion section of the attached case identifies uterine leiomyoma as a benign smooth muscle tumor containing variable amounts of fibrous tissue, typically surrounded by a pseudocapsule and supplied by one or two dominant feeding vessels. More than 90% arise within the uterine body.
Final Diagnosis
Uterine Leiomyoma (Fibroid)
The diagnosis is supported by the patient's symptoms and the characteristic MRI findings described in the attached case document.
Why Do These MRI Findings Occur?
The combination of low T2 signal intensity and isointense T1 signal reflects the dense smooth muscle and collagen-rich fibrous composition of a typical leiomyoma. Heterogeneous enhancement after contrast administration likely reflects variable vascularity and differences in tissue composition within the tumor. These imaging appearances correlate closely with the benign histologic architecture described in the source material.
6. Pathophysiology
Understanding Why Uterine Leiomyomas Develop
Although uterine leiomyomas are among the most common tumors encountered in gynecologic imaging, their biological behavior is remarkably complex. They are not simply "overgrown smooth muscle." Instead, they represent hormonally responsive monoclonal tumors that evolve through interactions among genetics, extracellular matrix remodeling, vascular biology, and endocrine signaling.
Understanding these mechanisms helps explain why MRI appearances vary considerably from one patient to another and why different leiomyomas respond differently to medical therapy or embolization.
Cellular Origin
Leiomyomas originate from a single mutated smooth muscle cell within the myometrium.
Unlike diffuse myometrial hyperplasia, every smooth muscle cell inside a leiomyoma is genetically identical, confirming their monoclonal origin.
Current molecular studies suggest that several driver mutations initiate abnormal proliferation.
The most common include:
- MED12 mutation (approximately 70%)
- HMGA2 overexpression
- FH mutation
- COL4A5/COL4A6 deletion
- Rare chromosomal rearrangements
Among these, MED12 mutations are now considered the dominant molecular pathway responsible for conventional uterine fibroids.
Hormonal Dependence
Leiomyomas are strongly estrogen- and progesterone-dependent tumors.
Neither hormone alone completely explains tumor growth.
Instead, estrogen increases progesterone receptor expression, while progesterone stimulates:
- Cellular proliferation
- Anti-apoptotic signaling
- Extracellular matrix production
- Angiogenesis
Consequently,
Fibroids enlarge during:
- reproductive years
- pregnancy
- hormonal stimulation
They typically regress after menopause.
This hormonal responsiveness explains why medical therapies targeting gonadotropin-releasing hormone (GnRH) pathways can significantly reduce tumor volume.
Extracellular Matrix: The Hidden Component
A defining feature of leiomyomas is their abundant extracellular matrix (ECM).
The ECM frequently occupies more volume than the smooth muscle cells themselves.
Major components include:
- Type I collagen
- Type III collagen
- Fibronectin
- Proteoglycans
This dense fibrous matrix explains many MRI characteristics.
For example,
The compact collagen network restricts free water mobility, producing the classic low T2 signal intensity seen in most conventional leiomyomas. The attached MRI case demonstrates this typical low-signal appearance on sagittal T2-weighted imaging.
Vascular Biology
Despite appearing highly vascular during surgery, most leiomyomas receive blood supply through only one or two dominant feeding arteries.
Their vascular architecture differs substantially from normal myometrium.
Typical findings include:
- Peripheral vascular network
- Relatively reduced central perfusion
- Variable capillary density
- Areas susceptible to ischemia
These vascular characteristics explain why:
- degeneration occurs
- infarction develops
- heterogeneous enhancement appears after contrast administration
Degenerative Changes
As fibroids enlarge, blood supply becomes insufficient.
This mismatch between growth and perfusion produces various forms of degeneration.
Common types include:
Hyaline degeneration
Most common (>60%)
MRI
- Low T2 signal
- Minimal enhancement
Cystic degeneration
Occurs after liquefaction.
MRI
- Very high T2 signal
- No internal enhancement
Red degeneration
Usually during pregnancy.
Caused by hemorrhagic infarction.
MRI
- High T1 signal
- Variable T2 signal
Calcific degeneration
Common after menopause.
Better demonstrated on CT than MRI.
Myxoid degeneration
Produces abundant mucopolysaccharide matrix.
MRI
- Very bright T2 signal
- Progressive enhancement
Recognizing these variants is essential because they may mimic uterine sarcoma.
Imaging–Pathophysiology Correlation
The MRI findings in this case closely reflect the underlying microscopic composition.
The lesion demonstrates:
- sharply defined margins
- low signal intensity on T2-weighted imaging
- isointense appearance on T1-weighted imaging
- heterogeneous post-contrast enhancement
These imaging characteristics correspond to a collagen-rich benign smooth muscle tumor supplied by peripheral vascular channels rather than diffuse infiltrative neovascularization.
Figure 2. Pathophysiology of Uterine Leiomyoma Development
Illustration demonstrating the progression from a genetically altered smooth muscle cell to a mature uterine leiomyoma. The figure highlights hormonal regulation, extracellular matrix accumulation, angiogenesis, degenerative pathways, and their corresponding MRI signal characteristics.
7. Epidemiology
Global Disease Burden
Uterine leiomyomas are the most common benign tumors of the female reproductive tract and one of the leading causes of gynecologic morbidity worldwide.
By the age of 50 years, imaging or pathological studies suggest that up to 70–80% of women have developed at least one fibroid. However, only a subset become symptomatic.
The attached case reflects a typical presentation in a reproductive-age woman with symptoms related to mass effect and abnormal uterine bleeding.
Age Distribution
The incidence increases rapidly after puberty.
Peak occurrence:
- 35–45 years
Rare before menarche.
Tumors generally regress after menopause due to declining ovarian hormone production.
Ethnic Differences
Marked racial disparities have been consistently reported.
Women of African ancestry:
- develop fibroids earlier
- have larger tumors
- present with multiple lesions more frequently
- undergo hysterectomy at younger ages
Major Risk Factors
Established risk factors include:
- Increasing reproductive age
- Family history
- Early menarche
- Obesity
- Hypertension
- Vitamin D deficiency
- Nulliparity
Protective factors include:
- Multiparity
- Long-term hormonal suppression
- Postmenopausal status
Clinical Impact
Leiomyomas represent one of the leading indications for:
- hysterectomy
- myomectomy
- uterine artery embolization
They are also a common cause of:
- infertility evaluation
- chronic pelvic pain
- abnormal uterine bleeding
- recurrent pregnancy loss in selected patients
Table 1. Epidemiology of Uterine Leiomyoma
| Variable | Summary |
|---|---|
| Lifetime prevalence | Up to 70–80% by age 50 |
| Symptomatic cases | Approximately 20–40% |
| Peak age | 35–45 years |
| Common location | Uterine corpus (>90%) |
| Major risk factors | Age, estrogen exposure, family history, obesity |
| Protective factors | Pregnancy, menopause |
| Geographic variation | Higher prevalence and severity reported in women of African ancestry |
8. Clinical Presentation
Clinical Manifestations
The clinical presentation depends primarily on:
- tumor size
- number of lesions
- anatomical location
- degenerative changes
Many leiomyomas remain asymptomatic and are discovered incidentally.
Symptomatic patients typically present because of abnormal uterine bleeding or mass effect.
Symptoms in This Case
The patient experienced:
- chronic pelvic pressure
- pelvic pain
- prolonged heavy menstrual bleeding
These symptoms are consistent with a large anterior wall leiomyoma compressing adjacent pelvic structures, including the urinary bladder, as demonstrated on MRI.
Common Clinical Symptoms
Abnormal uterine bleeding
Most frequent presentation.
Includes:
- heavy menstrual bleeding
- prolonged menstruation
- anemia
Bulk-related symptoms
Large fibroids may compress adjacent organs.
Patients may report:
- urinary frequency
- bladder pressure
- constipation
- pelvic fullness
The MRI in this case demonstrates anterior displacement of the bladder caused by the uterine mass.
Pain
Pain may result from:
- degeneration
- torsion of pedunculated fibroids
- rapid enlargement
- ischemia
Reproductive Symptoms
Depending on location:
- infertility
- implantation failure
- miscarriage
- preterm labor
may occur.
Physical Examination
Typical findings include:
- enlarged irregular uterus
- palpable pelvic mass
- lower abdominal fullness
- tenderness when degeneration occurs
Laboratory Findings
Frequently observed abnormalities include:
- iron deficiency anemia
- decreased hemoglobin
- reduced ferritin
- normal inflammatory markers
Red Flag Features
The following findings should prompt evaluation for malignant uterine neoplasms such as leiomyosarcoma:
- Rapid enlargement after menopause
- Irregular infiltrative margins on MRI
- Extensive necrosis without typical degeneration
- Diffuse restricted diffusion
- Markedly heterogeneous enhancement
- Systemic symptoms (weight loss, fever)
These imaging and clinical features differ from the well-circumscribed benign leiomyoma demonstrated in the present case.
9. Imaging Features
Radiologist-Level MRI Interpretation and Clinical Imaging Analysis
This section is based directly on the MRI findings described in the attached case study. The source document reports a large, well-defined uterine mass located in the anterior uterine wall that demonstrates low signal intensity on T2-weighted imaging, isointense signal intensity on T1-weighted imaging, and heterogeneous enhancement following contrast administration. The lesion displaces the urinary bladder anteriorly.
Figure 3. T2WI, Sagittal View (U: Uterus, B: Bladder, *: Leiomyoma)
Sagittal T2-weighted MRI demonstrates a large, sharply marginated mass arising from the anterior uterine wall. The lesion exhibits homogeneous low signal intensity relative to normal myometrium and compresses the urinary bladder anteriorly.
Radiologist Interpretation
Imaging Technique
- MRI
- Sagittal T2-weighted imaging
- High soft-tissue contrast evaluation
Location
- Anterior uterine wall
- Intramural dominant component
Morphology
- Round configuration
- Well-circumscribed borders
- Expansile growth pattern
Signal Characteristics
T2-weighted MRI
- Markedly low signal intensity
- Homogeneous appearance
Clinical Interpretation
The low T2 signal intensity reflects dense smooth muscle bundles intermixed with abundant collagen and extracellular matrix. This appearance is considered the classic MRI signature of a conventional uterine leiomyoma rather than a hypercellular or malignant uterine neoplasm. The MRI appearance directly correlates with the fibrous histologic composition described in the source material.
Why Does the Tumor Appear Dark on T2?
Water-rich tissues generally demonstrate high T2 signal.
Conventional leiomyomas contain:
- abundant collagen
- compact smooth muscle bundles
- reduced free water content
Consequently, proton mobility is restricted, resulting in the characteristic low T2 signal.
This finding is often the first clue suggesting a benign fibroid.
Figure 4. T1WI, Sagittal View (U: Uterus, B: Bladder, *: Leiomyoma)
Sagittal T1-weighted MRI reveals an isointense uterine mass relative to surrounding myometrium.
Radiologist Interpretation
Signal Characteristics
T1-weighted MRI
- Predominantly isointense
- No intrinsic hyperintense component
Clinical Meaning
The absence of T1 hyperintensity suggests that acute hemorrhage is unlikely.
The source document specifically notes that T1 hyperintensity should raise suspicion for hemorrhagic degeneration. This finding is not present in the current case.
Diagnostic Pearl
When evaluating uterine fibroids:
T1 Hyperintensity
→ Consider hemorrhage or red degeneration
T1 Isointensity
→ Typical uncomplicated leiomyoma
This distinction is particularly important when assessing symptomatic patients with acute pelvic pain.
Figure 5. Post-Contrast T1WI, Sagittal View (U: Uterus, B: Bladder, *: Leiomyoma)
Contrast-enhanced sagittal T1-weighted MRI demonstrates heterogeneous enhancement of the uterine mass.
Radiologist Interpretation
Enhancement Pattern
- Heterogeneous enhancement
- Preserved vascular supply
- No evidence of complete infarction
Pathophysiologic Meaning
Fibroids frequently exhibit heterogeneous enhancement because blood flow is not evenly distributed throughout the tumor.
Areas with:
- greater vascularity
- active cellular proliferation
enhance more strongly.
Less vascular fibrotic regions enhance less intensely.
Why Is Enhancement Important?
Contrast enhancement provides valuable information regarding:
- tumor viability
- vascular supply
- degeneration
- treatment planning
The source document notes that absence of enhancement should raise suspicion for partial or complete infarction of the fibroid.
Because enhancement is present in this case, the lesion remains viable.
Clinical Imaging Interpretation
Relationship Between MRI and Symptoms
The patient presented with:
- pelvic pain
- pelvic pressure
- prolonged heavy menstruation
MRI demonstrates a large anterior-wall fibroid displacing the bladder.
This explains the patient's symptoms.
Pelvic Pressure
Direct mass effect on adjacent pelvic organs.
Urinary Symptoms
Bladder compression may produce:
- urinary frequency
- urgency
- incomplete emptying
Menorrhagia
Distortion of uterine architecture can increase endometrial surface area and alter normal uterine contractility, resulting in excessive menstrual bleeding.
Diagnostic Imaging Pearls
Pearl 1: A well-defined uterine mass with low T2 signal strongly suggests a conventional leiomyoma.
Pearl 2: T1 hyperintensity should immediately raise suspicion for hemorrhagic degeneration.
Pearl 3: Absence of enhancement suggests infarction or severe degeneration.
Pearl 4: High T2 signal is not typical and may indicate:
- cellular leiomyoma
- myxoid degeneration
- sarcoma
Pearl 5: Well-circumscribed margins favor benign disease.
Irregular infiltrative margins warrant further evaluation.
Radiologist Reading Report
Findings
MRI demonstrates a large, well-circumscribed intramural mass arising from the anterior uterine wall.
The lesion demonstrates:
- low signal intensity on T2-weighted imaging
- isointense signal on T1-weighted imaging
- heterogeneous post-contrast enhancement
The mass exerts mass effect upon the urinary bladder, displacing it anteriorly.
No imaging evidence of aggressive local invasion is identified.
Impression
- Large anterior uterine intramural leiomyoma.
-
Typical MRI characteristics including:
- T2 hypointensity
- T1 isointensity
- heterogeneous enhancement
- Associated mass effect upon the urinary bladder.
- No MRI evidence suggesting malignant uterine neoplasm.
Clinical Correlation
Correlation with Symptoms
| Clinical Finding | MRI Correlation |
|---|---|
| Pelvic pressure | Large mass effect |
| Pelvic pain | Uterine distension and compression |
| Heavy menstruation | Uterine architectural distortion |
| Bladder symptoms | Anterior bladder displacement |
Correlation with Pathology
The imaging appearance corresponds to a benign smooth muscle neoplasm containing abundant fibrous stroma.
Supporting MRI features include:
- well-defined border
- low T2 signal
- absence of infiltrative growth
These findings are entirely consistent with the classic MRI description of leiomyoma reported in the source document.
Multimodal Imaging Comparison
| Imaging Modality | Strengths | Limitations | Clinical Value |
|---|---|---|---|
| Ultrasound | First-line screening | Operator dependent | Initial diagnosis |
| CT | Detects calcification | Limited soft-tissue contrast | Incidental detection |
| MRI | Best tissue characterization | Higher cost | Definitive evaluation |
| T2WI | Demonstrates fibrous content | Less vascular information | Typical fibroid diagnosis |
| T1WI | Detects hemorrhage | Lower lesion conspicuity | Degeneration assessment |
| Contrast MRI | Evaluates viability | Contrast required | Treatment planning |
Imaging Differential Diagnosis
| Disease | T2 Signal | Enhancement | Key Distinguishing Feature |
|---|---|---|---|
| Leiomyoma | Low | Variable | Well-defined border |
| Cellular Leiomyoma | High | Strong | Increased cellularity |
| Leiomyosarcoma | Heterogeneous | Irregular | Necrosis and invasion |
| Adenomyosis | Intermediate | Diffuse | Junctional zone thickening |
| Endometrial Stromal Sarcoma | Variable | Infiltrative | Myometrial invasion |
AI-Assisted Imaging Interpretation
What Would AI Detect First?
A modern MRI foundation model would likely identify:
- Enlarged uterus
- Uterine mass
- Mass boundary
- Relationship to bladder
- Signal characteristics
Radiomics Features
Potential quantitative biomarkers include:
- Shape irregularity
- Texture heterogeneity
- Entropy
- Signal uniformity
- Enhancement kinetics
Foundation Model Perspective
Large multimodal imaging models could integrate:
- MRI findings
- Symptoms
- Laboratory data
- Pathology
to generate differential diagnoses and treatment recommendations.
AI Limitations
AI may fail to recognize:
- unusual degeneration
- rare sarcoma variants
- subtle invasive features
- atypical enhancement patterns
Therefore, radiologist oversight remains essential.
Enterprise Clinical AI Workflow
Figure 6. AI-Assisted MRI Evaluation of Uterine Leiomyoma
Enterprise workflow illustrating MRI acquisition, automated lesion detection, radiomics feature extraction, foundation model analysis, radiologist validation, and integration into hospital PACS and EHR environments.
Imaging Summary
Most Important Imaging Finding
A large, well-circumscribed anterior uterine wall mass demonstrating classic MRI characteristics of leiomyoma.
Diagnostic MRI Feature
Low signal intensity on T2-weighted imaging.
Most Important Differential Point
The combination of sharp margins and low T2 signal strongly favors benign leiomyoma over uterine sarcoma.
Critical Clinical Takeaway
MRI not only confirms the diagnosis but also explains the patient's pelvic pressure, pain, and menorrhagia through direct visualization of bladder compression and uterine distortion.
10. Differential Diagnosis
Why Differential Diagnosis Matters
Although uterine leiomyomas are usually straightforward to diagnose on MRI, atypical degeneration, unusual signal characteristics, or rapid tumor enlargement may mimic malignant uterine tumors. Accurate differentiation is essential because treatment strategies vary considerably.
Table 2. MRI-Based Differential Diagnosis of Uterine Masses
| Disease | CT Findings | MRI Findings | Pathology | Key Differentiating Features |
|---|---|---|---|---|
| Leiomyoma | Well-defined soft tissue mass; calcification may be present | Low T2, T1 isointense, variable enhancement | Benign smooth muscle tumor | Well-circumscribed margins, low T2 signal |
| Cellular Leiomyoma | Similar to leiomyoma | Relatively high T2 signal, strong enhancement | Increased smooth muscle cellularity | Higher T2 signal than conventional leiomyoma |
| Leiomyosarcoma | Large heterogeneous mass with necrosis | Irregular margins, heterogeneous T2 signal, necrosis, hemorrhage | Malignant smooth muscle tumor | Infiltrative growth, extensive necrosis |
| Adenomyosis | Usually poorly visualized | Thickened junctional zone, ill-defined low T2 areas | Ectopic endometrial glands | Diffuse rather than focal lesion |
| Endometrial Stromal Sarcoma | Endometrial mass | Infiltrative myometrial invasion | Malignant stromal tumor | Worm-like extension into myometrium |
Imaging Clues Favoring Leiomyoma
The present case demonstrates several classic benign imaging characteristics:
- Well-defined margins
- Low T2-weighted signal intensity
- Isointense T1-weighted signal
- Heterogeneous but preserved enhancement
- Compression rather than invasion of adjacent organs
These findings are consistent with the MRI description provided in the source document.
11. Treatment
Treatment Strategy
Treatment should be individualized according to:
- Patient age
- Severity of symptoms
- Tumor size
- Tumor location
- Future fertility plans
- Imaging findings
Conservative Management
Asymptomatic fibroids generally require only periodic follow-up.
Management includes:
- Observation
- Serial ultrasound or MRI
- Clinical symptom monitoring
Medical Therapy
Medical options include:
- NSAIDs for pelvic pain
- Tranexamic acid for heavy menstrual bleeding
- Combined oral contraceptives
- Levonorgestrel-releasing intrauterine system
- GnRH agonists
- GnRH antagonists
- Selective progesterone receptor modulators (where approved)
These therapies primarily reduce symptoms and, in selected cases, temporarily decrease fibroid volume.
Minimally Invasive Procedures
Uterine Artery Embolization (UAE)
Indications:
- Symptomatic fibroids
- Desire to avoid hysterectomy
- No contraindication to embolization
MRI plays a central role in:
- Patient selection
- Vascular mapping
- Detection of degeneration
- Post-treatment assessment
MRI-Guided Focused Ultrasound
Advantages:
- Non-invasive
- Uterus-preserving
- Outpatient procedure
- MRI-guided targeting
Ideal candidates have:
- Limited number of fibroids
- Accessible lesion location
- Typical MRI characteristics
Surgical Treatment
Myomectomy
Preferred when fertility preservation is desired.
Approaches include:
- Hysteroscopic
- Laparoscopic
- Robotic-assisted
- Open surgery
Hysterectomy
Considered definitive treatment for:
- Large symptomatic fibroids
- Multiple recurrent lesions
- Patients without future fertility plans
AI-Assisted Treatment Planning
Emerging AI applications include:
- Automated fibroid segmentation
- Volumetric measurement
- Treatment response prediction
- UAE candidate selection
- Surgical planning using 3D reconstruction
These applications remain under active clinical investigation.
12. Prognosis
Overall Prognosis
Conventional uterine leiomyomas have an excellent prognosis.
Malignant transformation of a typical leiomyoma is considered extremely rare.
Symptom Outcome
Following appropriate treatment, most patients experience improvement in:
- Menorrhagia
- Pelvic pain
- Pelvic pressure
- Urinary symptoms
- Quality of life
Recurrence
Recurrence depends on treatment modality.
Approximate trends include:
| Treatment | Expected Recurrence |
|---|---|
| Myomectomy | Moderate |
| UAE | Low to moderate |
| Hysterectomy | None |
Follow-up Imaging
MRI follow-up is recommended when:
- Symptoms recur
- Degeneration is suspected
- Rapid enlargement occurs
- Fertility planning requires reassessment
Prognostic Imaging Indicators
Favorable findings include:
- Well-defined margins
- Typical low T2 signal
- Preserved enhancement
- Absence of invasive features
These characteristics are demonstrated in the present MRI case.
13. Artificial Intelligence Perspective
Enterprise AI Workflow for Uterine MRI
Figure 7. Enterprise AI Workflow for MRI-Based Uterine Leiomyoma Assessment
Conceptual workflow illustrating AI-assisted detection, segmentation, radiomics analysis, clinical decision support, radiologist validation, and integration into PACS and electronic health records through HL7/FHIR interoperability.
Radiomics
Quantitative MRI biomarkers may include:
- Tumor volume
- Shape irregularity
- Texture entropy
- Signal heterogeneity
- Enhancement kinetics
- Edge sharpness
These features may improve differentiation between benign and malignant uterine tumors.
Foundation Models
Large multimodal foundation models may integrate:
- MRI
- Ultrasound
- Clinical history
- Laboratory findings
- Operative reports
- Pathology
Potential outputs include:
- Automated differential diagnosis
- Risk estimation
- Follow-up recommendations
- Structured reporting support
Vision-Language Models
Future vision-language models may generate:
- Preliminary radiology reports
- Patient-friendly explanations
- Teaching annotations
- Multilingual reports
Radiologist verification remains essential.
AI Limitations
Current AI systems still have important limitations:
- Rare uterine sarcomas remain underrepresented in training datasets.
- Degenerative leiomyomas may mimic malignant tumors.
- Histopathological confirmation cannot be replaced by imaging AI alone.
- Clinical context remains indispensable.
14. Future of Precision Medicine
The future management of uterine leiomyomas is expected to evolve toward individualized care through integrated imaging, molecular biology, and artificial intelligence.
Radiogenomics
Correlation between MRI phenotypes and genetic alterations (e.g., MED12, HMGA2) may enable non-invasive molecular classification.
Digital Twin
Virtual patient models may simulate:
- Tumor growth
- Hormonal response
- Surgical planning
- Embolization outcomes
Federated Learning
Privacy-preserving collaborative AI training across hospitals could improve model robustness without sharing patient-identifiable data.
Synthetic Data
High-quality synthetic pelvic MRI datasets may help address the scarcity of rare cases while supporting algorithm development and validation.
Precision Imaging
Future MRI protocols may combine:
- Quantitative MRI
- Diffusion imaging
- Perfusion analysis
- Radiomics
- AI-driven image interpretation
to support personalized treatment selection.
Multimodal AI
Integration of imaging, genomics, pathology, laboratory data, and clinical history may enable comprehensive decision support and precision gynecologic care.
15. Clinical Pearls
- Uterine leiomyoma is the most common benign uterine tumor.
- MRI provides the highest soft-tissue contrast for lesion characterization.
- Low T2 signal is the classic imaging hallmark of conventional leiomyoma.
- T1 hyperintensity suggests hemorrhagic degeneration.
- Lack of contrast enhancement may indicate infarction or advanced degeneration.
- Well-defined margins favor benign pathology.
- MRI accurately demonstrates the relationship between the fibroid and adjacent pelvic organs.
- Imaging findings should always be interpreted in conjunction with symptoms.
- AI can assist lesion detection and volumetric analysis but cannot replace expert radiologic judgment.
- Multidisciplinary management improves treatment selection and long-term outcomes.
Quiz
1. Which MRI feature is most characteristic of a conventional uterine leiomyoma?
① High signal intensity on T2-weighted imaging
② Low signal intensity on T2-weighted imaging
③ Diffuse restricted diffusion with infiltrative margins
④ Marked T1 hyperintensity due to hemorrhage
⑤ Complete absence of enhancement in all lesions
Answer: ② Explanation: Conventional leiomyomas typically demonstrate low T2 signal intensity because of abundant collagen and smooth muscle content. This characteristic appearance is described in the attached case.
2. The patient's pelvic pressure is primarily explained by:
① Endometrial invasion
② Bladder compression by the uterine mass
③ Ovarian torsion
④ Pelvic inflammatory disease
⑤ Ascites
Answer: ② Explanation: The MRI demonstrates anterior displacement of the bladder by the leiomyoma, explaining the patient's pelvic pressure symptoms.
3. Which MRI sequence is most helpful for demonstrating the classic fibrous nature of a leiomyoma?
① Diffusion-weighted imaging
② T2-weighted imaging
③ MR angiography
④ Susceptibility-weighted imaging
⑤ MR spectroscopy
Answer: ② Explanation: The fibrous composition of leiomyomas produces low signal intensity on T2-weighted images.
4. Which MRI finding should raise concern for hemorrhagic degeneration?
① Low T2 signal
② T1 hyperintensity
③ Smooth margins
④ Uniform enhancement
⑤ Bladder displacement
Answer: ② Explanation: According to the source document, T1 hyperintensity suggests hemorrhage within the leiomyoma.
5. What is the most likely diagnosis in this case?
① Adenomyosis
② Leiomyosarcoma
③ Endometrial stromal sarcoma
④ Uterine leiomyoma
⑤ Ovarian fibroma
Answer: ④ Explanation: The patient's symptoms and MRI findings are classic for uterine leiomyoma.
Frequently Asked Questions (FAQ)
1. What is a uterine leiomyoma?
A benign smooth muscle tumor arising from the uterine myometrium.
2. Why is MRI performed?
MRI provides excellent soft-tissue contrast and accurately characterizes fibroid size, location, and degeneration.
3. Is a uterine leiomyoma cancer?
No. It is a benign tumor. Leiomyosarcoma is a separate malignant entity.
4. Why does the tumor appear dark on T2-weighted MRI?
Because it contains abundant collagen and tightly packed smooth muscle cells.
5. Can uterine fibroids cause infertility?
Yes. Depending on size and location, they may interfere with implantation or distort the uterine cavity.
6. What causes heavy menstrual bleeding?
Fibroids can distort uterine anatomy and impair normal uterine contraction, leading to excessive bleeding.
7. When is surgery recommended?
When symptoms are severe, fertility is affected, or conservative treatments fail.
8. Can AI diagnose uterine fibroids?
AI can assist with detection, segmentation, and volumetric analysis, but radiologist interpretation remains essential.
9. Is MRI always necessary?
No. Ultrasound is usually the first-line imaging modality, while MRI is used for detailed characterization or treatment planning.
10. What MRI finding most strongly supports a benign leiomyoma?
A well-defined uterine mass with low T2 signal intensity and preserved enhancement.
Conclusion
Uterine leiomyoma remains the most common benign neoplasm of the uterus and a major cause of gynecologic morbidity in women of reproductive age. Although often diagnosed with ultrasound, MRI has become the reference standard for detailed lesion characterization, treatment planning, and differentiation from malignant uterine tumors.
The present case illustrates the classic MRI appearance of a conventional leiomyoma: a well-circumscribed anterior uterine wall mass demonstrating low signal intensity on T2-weighted imaging, isointense signal on T1-weighted imaging, heterogeneous post-contrast enhancement, and mass effect on the urinary bladder. These imaging findings correlate closely with the patient's symptoms of pelvic pressure, pelvic pain, and heavy menstrual bleeding.
From an imaging perspective, recognizing the relationship between MRI signal characteristics and underlying pathology remains one of the most valuable skills in gynecologic radiology. At the same time, emerging artificial intelligence technologies—including automated segmentation, radiomics, and multimodal foundation models—are beginning to augment diagnostic workflows. Nevertheless, AI should be viewed as an assistive tool rather than a replacement for clinical expertise. The integration of advanced imaging, multidisciplinary collaboration, and responsible AI promises to further improve personalized care for women with uterine leiomyomas.
References
[1] H. Hricak, "MRI of the female pelvis: A review," American Journal of Roentgenology, vol. 146, no. 6, pp. 1115–1122, 1986. doi: 10.2214/AJR.146.6.1115.
[2] H. Hricak, D. Tscholakoff, L. Heinrichs, M. R. Fisher, G. C. Dooms, C. Reinhold, and R. B. Jaffe, "Uterine leiomyomas: Correlation of MR, histopathologic findings, and symptoms," Radiology, vol. 158, no. 2, pp. 385–391, 1986. doi: 10.1148/radiology.158.2.3753623.
[3] R. A. Kubik-Huch et al., "European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas," European Radiology, vol. 28, no. 8, pp. 3125–3137, 2018. doi: 10.1007/s00330-017-5157-5.
[4] W. Tu, M. Yano, N. Schieda, S. Krishna, L. Chen, R. V. Gottumukkala, and R. Alencar, "Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification," RadioGraphics, vol. 43, no. 6, 2023. doi: 10.1148/rg.220161.
[5] H. Hricak, "Widespread use of MRI in gynecology: A myth or reality?," Abdominal Imaging, vol. 22, no. 6, pp. 579–588, 1997. doi: 10.1007/s002619900267.
[6] R. A. Kubik-Huch et al., "European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas," European Radiology, vol. 28, pp. 3125–3137, 2018. doi: 10.1007/s00330-017-5157-5. (Recommended guideline for MRI protocol and reporting)
[7] A. Jha, M. Ascher, and R. Reinhold, "Practical Approach to MRI of Female Pelvic Masses," American Journal of Roentgenology, vol. 204, no. 6, 2015. doi: 10.2214/AJR.13.12023.
[8] Clinical Radiology Editorial Group, "Magnetic resonance imaging (MRI) of the myometrium – benign and malignant disease," Clinical Radiology, vol. 97, 2026, Art. no. 107281. doi: 10.1016/j.crad.2026.107281.
[9] H. Hricak, D. Tscholakoff, and R. B. Jaffe, "Uterine leiomyomas: Correlation of MR imaging with histopathology," Radiology, vol. 158, no. 2, pp. 385–391, 1986. doi: 10.1148/radiology.158.2.3753623.
[10] H. Hricak, "MRI of the female pelvis," American Journal of Roentgenology, vol. 146, no. 6, pp. 1115–1122, 1986. doi: 10.2214/AJR.146.6.1115. (Classic review article frequently cited in pelvic MRI literature)
Comments
Post a Comment